Funded Startups in Hainaut
Hainaut’s most recent disclosed rounds span from 2020-02-14 (OncoDNA, $19M) to 2025-11-17 (BOTALYS, $3M).
Hainaut’s most recent disclosed rounds span from 2020-02-14 (OncoDNA, $19M) to 2025-11-17 (BOTALYS, $3M). Across the seven listed companies, biotechnology dominates the sector mix: four of the seven entries are biotech (Santero Therapeutics on 2023-06-08 at $9M; Univercells on 2022-10-19 at $43M; Bone Therapeutics on 2021-12-03 at $4M; OncoDNA on 2020-02-14 at $19M).
Size-wise, Univercells’ $43M round (2022-10-19) stands out as the only disclosed amount far above the rest, with the next-largest disclosed figure coming from OncoDNA at $19M (2020-02-14). Geographic concentration appears in Gosselies, which hosts three biotech/IT companies across different stages and years (cikisi at $3M on 2023-09-01; Univercells at $43M on 2022-10-19; OncoDNA on 2020-02-14 at $19M), while the latest rounds cluster into the mid-2020s and early 2020s without a single city owning all recent activity.
Most recent rounds
7 shownRelated listings
Frequently asked
Which disclosed round is the size outlier in Hainaut, and how do the others compare?
Univercells’ $43M round on 2022-10-19 is the clear outlier in disclosed amounts, dwarfed by the next-largest disclosed round of $19M from OncoDNA on 2020-02-14.
Do biotech and non-biotech companies cluster together in this Hainaut dataset?
Yes. Four of seven entries are biotech (Santero Therapeutics $9M on 2023-06-08; Univercells $43M on 2022-10-19; Bone Therapeutics $4M on 2021-12-03; OncoDNA $19M on 2020-02-14), while the remaining three cover Agriculture and Farming (BOTALYS, $3M on 2025-11-17), Information Technology (cikisi, $3M on 2023-09-01), and Education (myskillcamp, $14M on 2021-09-06).
Is there a city that appears repeatedly, suggesting a local cluster?
Gosselies is the repeated city: cikisi (IT) closed a $3M Seed on 2023-09-01, Univercells (Biotech) raised $43M on 2022-10-19, and OncoDNA (Biotech) has a $19M round dated 2020-02-14. Other cities appear once each in the visible rows (Ghislenghien, Charleroi, Tournai).
What stage mix dominates, and where do unknown stage entries show up?
Stages are split, with biotech appearing across multiple stages (Series D for Univercells at $43M on 2022-10-19; Series A for Santero Therapeutics at $9M on 2023-06-08; Post-IPO Equity for Bone Therapeutics at $4M on 2021-12-03) plus one blank/unspecified stage for OncoDNA on 2020-02-14 at $19M. Seed is represented by cikisi ($3M on 2023-09-01), and Convertible Note appears once via BOTALYS ($3M on 2025-11-17).
Are there tight temporal clusters among the most recent Hainaut rounds shown?
The newest activity is concentrated in the most recent 3 entries by date: BOTALYS ($3M on 2025-11-17), cikisi ($3M on 2023-09-01), and Santero Therapeutics ($9M on 2023-06-08). The remaining four rounds extend earlier (2022-10-19 back to 2020-02-14), with no additional mid-2020s entries beyond 2023 and 2025.
Which is the smallest disclosed round, and does it sit in a broader pattern?
The smallest disclosed amount is $3M, appearing twice: BOTALYS (Convertible Note, 2025-11-17) and cikisi (Seed, 2023-09-01). Both are non-biotech entries in this view (Agriculture and Farming; Information Technology), while biotech disclosed amounts range from $4M to $43M.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.